Tilray Posts Record Revenue for Fiscal 2026, but Shares Fail to Rally

Tilray reported record revenue for fiscal 2026, a milestone that would typically be treated as good news for a company that has struggled with profitability since cannabis legalization spread across more U.S. states and parts of Canada. Instead, the stock did not rally on the report. The muted reaction suggests investors are looking past the top-line number. Record revenue alone does not address whether Tilray is converting sales into sustainable profit, and legalization progress across new markets has so far not been the game-changer for the stock that bulls have argued it should be. What is unresolved is whether Tilray's cost structure and cannabis pricing pressure will eventually catch up with, or continue to offset, revenue growth. The company has not indicated when it expects consistent profitability.